AT
Adam Taich sold $3M of TXG stock
Adam Taich, Chief Financial Officer of 10x Genomics, Inc. (TXG), sold 46,388 shares of TXG stock worth $3M, per an SEC Form 4 filed Sep 11, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 9, 2026, 2 days before it was made public.
TXG has moved -12.2% since the trade date, from $67.29 to $59.10 (Nov 12, 2026 close).
- Traded
- Sep 9, 2026
- Disclosed
- Sep 11, 2026
- Filing delay
- 2 days
- Price since
- -12.2%
- Role
- Chief Financial Officer
- Source
- SEC Form 4